Urgent.News

What's breaking now, across hundreds of outlets.

Health & Medicine

In the hunt for reverse merger targets, Caribou could be prized game

The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Source: biopharmadive.com

Read the original at biopharmadive.com →

Report a problem with this story

More in Health & Medicine

More from Thursday 8 October →